Search results
Showing 6601 to 6615 of 7708 results
Vision Amniotic Leak Detector to assess unexplained vaginal wetness in pregnancy (MTG15)
In March 2019, NICE reviewed this guidance and recommended it should be withdrawn because Vision Amniotic Leak Detector is no longer available. NICE has produced a medtech innovation briefing on AmnioSense for unexplained vaginal wetness in pregnancy. For a copy of the review decision, please contact nice@nice.org.uk.
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26)
This guidance has been updated and replaced by NICE medical technologies guidance 58.
The TURis system for transurethral resection of the prostate (MTG23)
This guidance has been updated and replaced by NICE medical technologies guidance 53.
GreenLight XPS for treating benign prostatic hyperplasia (MTG29)
This guidance has been updated and replaced by NICE medical technologies guidance 74.
This medical technologies guidance has been replaced by the recommendation on cardiac output monitoring in the NICE guideline on perioperative care in adults.
This guidance has been updated and replaced by NICE medical technologies guidance 75.
Inditherm patient warming mattress for the prevention of inadvertent hypothermia (MTG7)
In March 2018, NICE reviewed this guidance and recommended it should be withdrawn as it has been updated and replaced by the NICE guideline on hypothermia: prevention and management in adults having surgery. For a copy of the review decision please contact nice@nice.org.uk.
BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain (MTG4)
In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.
This advice has been updated and replaced by NICE diagnostics guidance 34.
This advice has been updated and replaced by NICE medical technologies guidance 47.
AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35)
This advice has been updated and replaced by NICE medtech innovation briefing 232.
The BCM – Body Composition Monitor for managing fluid in people having dialysis (MIB41)
This advice has been updated and replaced by NICE diagnostics guidance 29.
Self-harm in over 8s: short-term management and prevention of recurrence (CG16)
This guidance has been updated and replaced by NICE guideline NG225.
Fever in under 5s: assessment and initial management (CG160)
This guidance has been updated and replaced by NICE guideline NG143.
This guidance has been updated and replaced by NICE guideline NG236.